iVascular, founded in 2010 and headquartered in Germany, is a pioneering force in the Biotechnology and Medical Devices sector. Their mission, encapsulated in the slogan “Therapies for living,” is to create cutting-edge medical devices and therapies that address cardiovascular disorders effectively.
One of the standout features of iVascular is its robust vertical integration strategy. The company excels in transforming basic raw materials such as plastics and metals into advanced cardiovascular devices. This seamless integration from design to production ensures high-quality standards and efficiency.
The company's innovation is driven by a diverse team skilled in biopolymers, coatings, and drug delivery systems. iVascular oversees an expansive technology center featuring over 1000 m² of ISO standard clean rooms, supporting their substantial capabilities in R&D and production.
With a presence in more than 70 countries, iVascular has established an extensive global footprint, offering a comprehensive range of products for interventional cardiology and endovascular procedures.